Evidence map›Paper›PMID 33169106›Full record

ArticleOne health (Amsterdam, Netherlands)2021

High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households.

Matthieu Fritz, Béatrice Rosolen, Emilie Krafft, Pierre Becquart, Eric Elguero, Oxana Vratskikh, Solène Denolly, Bertrand Boson, Jessica Vanhomwegen, Meriadeg Ar Gouilh and 5 more

Open access · goldAbstract read
In one paragraph

Article in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 1 synthesis or guideline pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Ultrafast and high-throughput immunoassay assay to detect anti-SARS-CoV-2 IgG antibodies in dogs and cats.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Matthieu FritzInstitut de Recherche pour le Développement (IRD), Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - Université de Montpellier), Montpellier, France.
Béatrice RosolenService de Maladies Infectieuses et Tropicales, CHRU hôpital Jean-Minjoz, Besançon, France.
Emilie KrafftUniversité de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Marcy-l'Etoile, France.
Pierre BecquartInstitut de Recherche pour le Développement (IRD), Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - Université de Montpellier), Montpellier, France.
Eric ElgueroInstitut de Recherche pour le Développement (IRD), Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - Université de Montpellier), Montpellier, France.
Oxana VratskikhEnvironment and Infectious Risk Unit, Laboratory for Urgent Response to Biological Threats, Institut Pasteur, Paris, France.
Solène DenollyCIRI - Centre International de Recherche en Infectiologie, Team EVIR, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U111, CNRS, UMR5308, ENS Lyon, Lyon, France.
Bertrand BosonCIRI - Centre International de Recherche en Infectiologie, Team EVIR, Université de Lyon, Université Claude Bernard Lyon 1, INSERM, U111, CNRS, UMR5308, ENS Lyon, Lyon, France.
Jessica VanhomwegenEnvironment and Infectious Risk Unit, Laboratory for Urgent Response to Biological Threats, Institut Pasteur, Paris, France.
Meriadeg Ar GouilhGroupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Université, 14000 Caen, France.
Angeli KodjoUniversité de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Marcy-l'Etoile, France.
Catherine ChirouzeService de Maladies Infectieuses et Tropicales, CHRU hôpital Jean-Minjoz, Besançon, France.
Serge G RosolenSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Vincent LegrosUniversité de Lyon, VetAgro Sup, Campus Vétérinaire de Lyon, Marcy-l'Etoile, France.
Eric M LeroyInstitut de Recherche pour le Développement (IRD), Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (IRD 224 - CNRS 5290 - Université de Montpellier), Montpellier, France.
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRInstitut Pasteur · FRNormandie Université · FRUniversité de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.

Indexed as

COVID-19LuminexNeutralization assayOne healthPetsSARS-CoV-2Seroprevalence

Identifiers

PMID33169106
PMCPMC7641531
OpenAlexW3100059438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.